“Dupilumab With Concomitant Topical Corticosteroids in Atopic Dermatitis Patients Who Are Inadequately Controlled With or Medically Inadvisable for Cyclosporine A: A Phase 3 Clinical Trial (LIBERTY AD CAFE)”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s37, https://doi.org/10.25251/skin.1.supp.36.